Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcranial Alternating Current Stimulation in Post Stroke Aphasia Therapy

NCT: NCT07510464 · COMPLETED

NCT IDNCT07510464
StatusCOMPLETED
Start Date2019-12-01
Completion2021-12-30

Brief Summary

This study aims to investigate the efficacy of transcranial alternating current stimulation (tACS) combined with linguistic training for patients with chronic post-stroke aphasia. Thirteen patients will participate in a randomized crossover clinical trial. Their naming ability will be assessed before and after two-weeks of therapy (with 16 days of washout) supported by either 75Hz tACS or sham stimulation. The stimulated cortical area will be selected individually based on the results of functional magnetic resonance imaging.

Frequently Asked Questions

What is Transcranial Alternating Current Stimulation in Post Stroke Aphasia Therapy?

Transcranial Alternating Current Stimulation in Post Stroke Aphasia Therapy is a clinical trial registered under NCT07510464. Current status: COMPLETED.

What is the status of NCT07510464?

The current status of NCT07510464 (Transcranial Alternating Current Stimulation in Post Stroke Aphasia Therapy) is: COMPLETED.

When did Transcranial Alternating Current Stimulation in Post Stroke Aphasia Therapy start?

Transcranial Alternating Current Stimulation in Post Stroke Aphasia Therapy started on 2019-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.